404 related articles for article (PubMed ID: 37766615)
1. N6-methyladenosine (m6A) modification in osteosarcoma: expression, function and interaction with noncoding RNAs - an updated review.
Zhang Y; Xu Y; Bao Y; Luo Y; Qiu G; He M; Lu J; Xu J; Chen B; Wang Y
Epigenetics; 2023 Dec; 18(1):2260213. PubMed ID: 37766615
[TBL] [Abstract][Full Text] [Related]
2. Novel insights into the interaction between N6-methyladenosine methylation and noncoding RNAs in musculoskeletal disorders.
Han J; Kong H; Wang X; Zhang XA
Cell Prolif; 2022 Oct; 55(10):e13294. PubMed ID: 35735243
[TBL] [Abstract][Full Text] [Related]
3. N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer.
Ge Y; Liu T; Wang C; Zhang Y; Xu S; Ren Y; Feng Y; Yin L; Pu Y; Liang G
RNA Biol; 2021 Nov; 18(sup2):551-561. PubMed ID: 34674600
[TBL] [Abstract][Full Text] [Related]
4. Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment.
Wang D; Han Y; Peng L; Huang T; He X; Wang J; Ou C
Int J Biol Sci; 2023; 19(7):2198-2219. PubMed ID: 37151887
[TBL] [Abstract][Full Text] [Related]
5. Circular RNAs, Noncoding RNAs, and N6-methyladenosine Involved in the Development of MAFLD.
Nakashima M; Suga N; Ikeda Y; Yoshikawa S; Matsuda S
Noncoding RNA; 2024 Feb; 10(1):. PubMed ID: 38392966
[TBL] [Abstract][Full Text] [Related]
6. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
[TBL] [Abstract][Full Text] [Related]
7. The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications.
Liu Z; Gao L; Cheng L; Lv G; Sun B; Wang G; Tang Q
Exp Mol Med; 2023 Mar; 55(3):487-501. PubMed ID: 36854773
[TBL] [Abstract][Full Text] [Related]
8. Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment.
Zhang Y; Zhan L; Li J; Jiang X; Yin L
Aging (Albany NY); 2023 May; 15(9):3857-3889. PubMed ID: 37178254
[TBL] [Abstract][Full Text] [Related]
9. The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications.
Qin S; Mao Y; Wang H; Duan Y; Zhao L
Int J Biol Sci; 2021; 17(11):2718-2736. PubMed ID: 34345203
[TBL] [Abstract][Full Text] [Related]
10. Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.
Zhang G; Hou J; Mei C; Wang X; Wang Y; Wang K
Biomed Pharmacother; 2023 Mar; 159():114260. PubMed ID: 36657303
[TBL] [Abstract][Full Text] [Related]
11. The interplay between m6A RNA methylation and noncoding RNA in cancer.
Ma S; Chen C; Ji X; Liu J; Zhou Q; Wang G; Yuan W; Kan Q; Sun Z
J Hematol Oncol; 2019 Nov; 12(1):121. PubMed ID: 31757221
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer.
Huang X; Guo H; Wang L; Yang L; Shao Z; Zhang W
Mol Ther Nucleic Acids; 2022 Mar; 27():947-955. PubMed ID: 35211355
[TBL] [Abstract][Full Text] [Related]
13. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
Front Immunol; 2021; 12():806189. PubMed ID: 35095893
[TBL] [Abstract][Full Text] [Related]
14. Novel insights into the interplay between m
Yi YC; Chen XY; Zhang J; Zhu JS
Mol Cancer; 2020 Aug; 19(1):121. PubMed ID: 32767982
[TBL] [Abstract][Full Text] [Related]
15. Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance.
Lin H; Wang Y; Wang P; Long F; Wang T
Mol Cancer; 2022 Jul; 21(1):148. PubMed ID: 35843942
[TBL] [Abstract][Full Text] [Related]
16. Interaction between m6A and ncRNAs and Its Association with Diseases.
Chen S; Dong J; Luo X; Nie Z; Lu S; Liu H; Liu J
Cytogenet Genome Res; 2022; 162(4):171-187. PubMed ID: 36122561
[TBL] [Abstract][Full Text] [Related]
17. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
[No Abstract] [Full Text] [Related]
18. Methylation recognition protein YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) regulates the proliferation, migration and invasion of osteosarcoma by regulating m6A level of CCR4-NOT transcription complex subunit 7 (CNOT7).
Wei K; Gao Y; Wang B; Qu YX
Bioengineered; 2022 Mar; 13(3):5236-5250. PubMed ID: 35156522
[TBL] [Abstract][Full Text] [Related]
19. Interaction between m6A methylation and noncoding RNA in glioma.
Tao N; Wen T; Li T; Luan L; Pan H; Wang Y
Cell Death Discov; 2022 Jun; 8(1):283. PubMed ID: 35688823
[TBL] [Abstract][Full Text] [Related]
20. Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma.
Zhang W; Wu W; Meng Q; Yang L; Yuan J; Tian Z; Ding R; Zhang X; Wang J; Tao K
Front Oncol; 2022; 12():907399. PubMed ID: 35936671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
